Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Cabotegravir 600mg/3ml prolonged-release suspension for injection vials |
| BNF code | 0503010AWAAABAB |
| Virtual Therapeutic Moiety | Cabotegravir |
| Abbreviated name | Cabotegravir 600mg/3ml prolonged-release inj vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 3.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Cabotegravir |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 200.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninjectionprolonged-release.intramuscular |
| Dose Form | |
| Formulation | Prolonged-release suspension for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Apretude 600mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) | |
| Vocabria 600mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Cabotegravir 600mg/3ml prolonged-release suspension for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_10.3.0_20251027000001, imported on 28th October 2025 at 04:07:32.